Quarterly results for HealthCare Global Enterprises Ltd

HealthCare Global Enterprises Limited
Quarterly Results Announcement: 01 August 2025

• Revenue: Consolidated revenue for Q1 FY26 stood at Rs. 61,180 lakhs, up 16.6% YoY (Rs. 52,469 lakhs in Q1 FY25) and 4.9% QoQ (Rs. 58,343 lakhs in Q4 FY25). Standalone revenue increased 4% YoY to Rs. 32,593 lakhs.
• Profitability: Consolidated profit after tax (PAT) declined to Rs. 598 lakhs in Q1 FY26 from Rs. 1,363 lakhs in Q1 FY25 and Rs. 677 lakhs in Q4 FY25. Basic EPS (consolidated) was Rs. 0.34 (not annualised), down from Rs. 0.87 in Q1 FY25. Standalone PAT was Rs. 345 lakhs.
• Margins: EBITDA and EBITDA margin figures were not explicitly disclosed.
• Balance Sheet / Capital: No specific capex or debt changes disclosed. Goodwill recognized on acquisitions: Rs. 4,169 lakhs (Indore cancer centre) and Rs. 20,695 lakhs (Vizag Hospital).
• Acquisitions: Completed acquisition of Indore cancer care centre (Oct 2023) and 51% stake in Vizag Hospital and Cancer Research Centre Private Limited (Oct 2024), with commitment to acquire an additional 34% within 18 months.
• Corporate Transactions: KKR affiliates acquired 51.59% stake at Rs. 445/share on 30 May 2025; open offer ongoing to acquire up to 26% at Rs. 504.41/share (open until 1 Aug 2025). Promoter status changed accordingly.
• ESOP: Amendment approved allowing cash settlement; 1.62 million options surrendered in Q1 FY26 with Rs. 5,808 lakhs paid; accelerated vesting expense of Rs. 69 lakhs recognized.
• Taxation: Deferred tax credit of Rs. 1,410 lakhs recognized in FY25 on subsidiary losses.
• Impairment: FY25 standalone included Rs. 3,482 lakhs impairment on investment in HCG NCHRI Oncology LLP.
• Segment: Operates in a single segment—hospital and medical diagnostic services.
• Auditor’s Report: Unqualified limited review report with no qualifications or issues.

This summary reflects the company’s consolidated and standalone financials, key acquisitions, corporate restructuring, and management commentary for Q1 FY26.

Note: This is an AI generated summary of the results. There may be inaccuracies in the summary. Please refer to the original document before making investment decisions.